T. Rowe Price Associates
LFMD icon

T. Rowe Price Associates’s LifeMD LFMD Stock Holding History

T. Rowe Price Associates’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Hold
28,579
– – ﹤0.01% 3122
2026
Q1 		$104K Buy
28,579
+9,297
+48% +$32.2K ﹤0.01% 2994
2025
Q4 		$66K Hold
19,282
– – ﹤0.01% 3004
2025
Q3 		$131K Buy
19,282
+1,529
+9% +$12.6K ﹤0.01% 2877
2025
Q2 		$242K Buy
17,753
+1,470
+9% +$13.9K ﹤0.01% 2623
2025
Q1 		$89K Buy
16,283
+2,271
+16% +$12.9K ﹤0.01% 2845
2024
Q4 		$70K Buy
14,012
+2,895
+26% +$15.2K ﹤0.01% 2888
2024
Q3 		$59K Hold
11,117
– – ﹤0.01% 2908
2024
Q2 		$0 Buy
+11,117
New +$102K ﹤0.01% 2979
2022
Q3 		– Sell
-18,900
Closed -$39K – 3009
2022
Q2 		$39K Hold
18,900
– – ﹤0.01% 2886
2022
Q1 		$67K Hold
18,900
– – ﹤0.01% 2898
2021
Q4 		$73K Hold
18,900
– – ﹤0.01% 2905
2021
Q3 		$117K Sell
18,900
-6,100
-24% -$52K ﹤0.01% 2819
2021
Q2 		$295K Buy
+25,000
New +$288K ﹤0.01% 2604

Other funds holding LFMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

T. Rowe Price Associates's LFMD Position: Q2 2026 in Review

T. Rowe Price Associates held its LifeMD (LFMD) position steady in Q2 2026 at 28,579 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #3122.

T. Rowe Price Associates first reported a position in LFMD in Q2 2021 and has held it in 14 quarters since. The position peaked at $295K in Q2 2021. 115 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • T. Rowe Price Associates held 28,579 shares of LifeMD worth $119K as of Q2 2026.
  • T. Rowe Price Associates left its LifeMD share count unchanged in Q2 2026.
  • LifeMD made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #3122 holding.
  • T. Rowe Price Associates first reported a position in LifeMD in Q2 2021 and has held it in 14 quarters since.
  • T. Rowe Price Associates's LifeMD position peaked at $295K in Q2 2021.
  • 115 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.